D-0623-2024 Class II Ongoing

Recalled by FDC Limited — Aurangabad, Maharashtra State, N/A

FDA drug recall D-0623-2024 was initiated by FDC Limited on Jul 23, 2024 and is designated Class II. Reason for recall: Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle. The recall status is ongoing. Affected quantity: 66,528 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 7, 2024
Initiation Date
Jul 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
66,528 bottles

Product description

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Reason for recall

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Distribution pattern

U.S. A. Nationwide

Code information

Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0623-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0623-2024. Report a data issue: hello@regdatalab.com.